Cover Image

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma

Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor, which poses a serious threat to human health. Histone 3 lysine 9 trimethylation (H3K9me3) is a post-translational modification involved in regulating a broad range of biological processes and has been considered as poten...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sheng Hu (Author), Xuejun Wang (Author), Tao Wang (Author), Lianmin Wang (Author), Lixin Liu (Author), Wenjun Ren (Author), Xiaoyong Liu (Author), Weihan Zhang (Author), Weiran Liao (Author), Zhoujun Liao (Author), Renchao Zou (Author), Xiaowen Zhang (Author)
Format:	Book
Published:	BMC, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intrahepatic cholangiocarcinoma after the Fontan procedure
by: Yuichi Shibui, et al.
Published: (2019)

Intrahepatic Cholangiocarcinoma Skin Metastasis in a Patient with Hidradenitis Suppurativa: A Rare Entity
by: Ali Y Fakhreddine, et al.
Published: (2020)

Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
by: Mina Komuta
Published: (2024)

Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma
by: Mayur Parkhi, et al.
Published: (2023)

Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma
by: Yang Z, et al.
Published: (2022)

Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
by: Lulu Xie, et al.
Published: (2022)

HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2023)

Along for the Ride: Intrahepatic Cholangiocarcinoma with Concomitant LECT2 Amyloidosis
by: Phoenix D. Bell, et al.
Published: (2020)

Biocompatible Snowman-like Dimer Nanoparticles for Improved Cellular Uptake in Intrahepatic Cholangiocarcinoma
by: Ruyin Chen, et al.
Published: (2023)

Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2024)

Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
by: Jing Bian, et al.
Published: (2022)

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
by: He C, et al.
Published: (2021)

Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma
by: Zhao-Ru Dong, et al.
Published: (2024)

Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
by: Yanxin Sun, et al.
Published: (2024)

Presentation of Intrahepatic Cholangiocarcinoma with Fulminant Hepatic Failure: A Case Report
by: Thara Pratap, et al.
Published: (2019)

A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma
by: Pei Zhang, et al.
Published: (2024)

Uncovering the mechanism of Kang-ai injection for treating intrahepatic cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation
by: Fei Song, et al.
Published: (2023)

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis
by: Cindy Neuzillet, et al.
Published: (2022)

Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration
by: Lavinia Patricia Mocan, et al.
Published: (2024)

Intrahepatic cholangiocarcinoma developing seven years after resection of congenital biliary dilatation
by: Kanako Omata, et al.
Published: (2020)

A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma
by: Zhenzhen Chu, et al.
Published: (2023)

Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation
by: Ao Ren, et al.
Published: (2021)

Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation-like Feature Associated with Bile Duct Adenoma
by: Ah-Young Kwon, et al.
Published: (2015)

Exosomal circ-PTPN22 and circ-ADAMTS6 mark T cell exhaustion and neutrophil extracellular traps in Asian intrahepatic cholangiocarcinoma
by: Xuezhu Wang, et al.
Published: (2023)

Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma
by: Zhenyun Yang, et al.
Published: (2023)

Untargeted UPLC-MS-based metabolomics analysis reveals the metabolic profile of intrahepatic cholangiocarcinoma process and the intervention effect of Osthole in mice
by: Xin Chen, et al.
Published: (2022)

Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link
by: Giovanni Brandi, et al.
Published: (2022)

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
by: Yeh CN, et al.
Published: (2014)

Small duct type intrahepatic cholangiocarcinoma with extensive intraductal extension mimics an intraductal tubulopapillary neoplasm
by: Mark Fowler, et al.
Published: (2023)

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
by: Kang-shuai Li, et al.
Published: (2024)

MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma
by: Hao Xu, et al.
Published: (2022)

Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFkB pathways in cholangiocarcinoma cells
by: Ke FY, et al.
Published: (2017)

Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review
by: Zhi-Kai Zheng, et al.
Published: (2022)

Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report
by: Aram A. Musaelyan, et al.
Published: (2024)

First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma
by: Olaf Neumann, et al.
Published: (2023)

The DPY30-H3K4me3 Axis-Mediated PD-L1 Expression in Melanoma
by: Zhang Z, et al.
Published: (2022)

Population-pharmacokinetic/pharmacodynamic model of atractylodes lancea (Thunb.) DC. administration in patients with advanced-stage intrahepatic cholangiocarcinoma: a dosage prediction
by: Teerachat Saeheng, et al.
Published: (2024)

Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of patients with biliary tract cancer, especially with intrahepatic cholangiocarcinoma
by: Takafumi Yanaidani, et al.
Published: (2024)

The role of Ca2+ signalling and InsP3R in the pathogenesis of intrahepatic cholestasis of pregnancy
by: Dan Pan, et al.
Published: (2024)

Case report: Immunotherapy plus chemotherapy and stereotactic ablative radiotherapy (ICSABR): a novel treatment combination for Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma
by: Ruizhen Li, et al.
Published: (2023)